Eur J Gastroenterol Hepatol
September 2011
Background And Aims: We completed a retrospective analysis of patients with genotype 3 hepatitis C virus (HCV) undergoing therapy in four UK centres with large populations of patients from the Indian subcontinent.
Materials And Methods: Notes on all patients treated with pegylated interferon and ribavirin were reviewed and factors that influenced the response were examined.
Results: Six hundred and four patients with genotype 3 HCV were studied, of whom 299 were Asians.